Beyond the Scale: Muscle-Preserving Weight Loss Innovations in 2026
The first generation of obesity drugs faced a critical clinical challenge: nearly 25-40% of the weight lost was comprised of lean muscle and bone mass. In 2026, the focus has…
The first generation of obesity drugs faced a critical clinical challenge: nearly 25-40% of the weight lost was comprised of lean muscle and bone mass. In 2026, the focus has…